This finding is bolstered by evidence indicating that blocking VCAM-1 prevents the adhesion and migration of monocytes across the endothelium, thus hindering the progression of MASLD (74). The gene discussed is VCAM1; the disease is metabolic dysfunction-associated steatotic liver disease.